Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Breeze Holdings Acquisition (BREZU)
Upcoming IPO
AMMO (POWW)
Vision Marine Technologies (VMAR)
Spring Valley Acquisition (SVSVU)
Genesis Park Acquisition (GNPK.U)
Ozon Holdings Plc (OZON)
Tiga Acquisition (TINVU)
Spartan Acquisition Corp. II (SPRQ.U)
Priced IPO
Sotera Health Company (SHC)
Maravai LifeSciences Holdings, Inc. (MRVI)
Telos Corporation (TLS)
NeoGames S.A (NGMS)
Olema Pharmaceuticals, Inc. (OLMA)
Yatsen Holding Limited (YSG)
Lufax Holding Ltd (LU)
Atea Pharmaceuticals, Inc. (AVIR)
SQZ Biotechnologies Company (SQZ)
Allegro MicroSystems, Inc. (ALGM)
Galecto, Inc. (GLTO)
Leslie's Inc (LESL)
Gatos Silver, Inc. (GATO)
Biodesix, Inc. (BDSX)
MediaAlpha, Inc. (MAX)
Root, Inc. (ROOT)
Absolute Software (ABST)
EQT Corporation (EQT)
Foghorn Therapeutics Inc. (FHTX)
McAfee Corp. (MCFE)
More companies

Abcam plc (ABCM)

Sector - Healthcare

Price chart

Company News

IPO Profile

About company

They are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for their customers at the forefront of life science research. Their products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. Their mission is to provide life science researchers with highly validated products and services to advance biological research and achieve their goals faster. They do this by continuously innovating and providing their customers with high-quality tools, together with expert customer support. Their product offering includes an extensive portfolio of antibodies and related protein research tools that are fundamental to their customers’ research and experimental workflow. Their customers are primarily scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies. Headquartered in Cambridge, United Kingdom, they operate across 15 locations around the world, supported by their world-class team of approximately 1,500 employees, including over 200 with PhDs, and have served customers in over 130 countries.
Industry
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
CEO CFO
Alan Hirzel Michael Baldock
Employees Founded
1500 1998

Contacts

Address: Discovery Drive Cambridge Biomedical Campus Cambridge, CB2 0AX United Kingdom

Telephone: +44 (0) 1223 696000

Web page: http://www.abcamplc.com

IPO information

Expected Date 10/22/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Financial Data (last reporting year)

Market Cap (MM) $3719.8
Revenues (MM) $321.6
Net Income (Loss) (MM) $15.5

Voting

What do you think will happen with the ABCM share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Shares Initial (MM) 8.95
Shares Revised (MM) 8.95
Expected offer amount (MM) $147.85
Realized offer amount(MM) $156.63
Underwriters
Morgan Stanley/ BofA Securities/ SVB Leerink
CO-Managers
Lazard/ William Blair

Sector: Healthcare

Tweets about $ABCM

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats